Expertise in
62
conditions

Dr. Adedayo Onitilo

Oncology
Marshfield Medical Center-Weston Medical Offices-Cancer Care
3400 Ministry Pkwy, 
Weston, WI 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Expertise in
62
conditions
Marshfield Medical Center-Weston Medical Offices-Cancer Care
3400 Ministry Pkwy, 
Weston, WI 

Overview

Adedayo Onitilo is an Oncologist practicing medicine in Weston, Wisconsin.

Dr. Onitilo is highly rated in 62 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Breast Cancer, Colorectal Cancer, Pancreaticoduodenectomy, and Gallbladder Removal.

He is actively involved in clinical research, co-authoring 118 peer reviewed articles and participating in 34 clinical trials.

Specialties

Oncology

Licenses

Internal Medicine in WI

Hospital Affiliations

Marshfield Medical Center - Weston
Flambeau Hospital
Marshfield Medical Center
Marshfield Medical Center - Minocqua

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health Plan
  • INSURANCE PLAN
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Marshfield Medical Center-Weston Medical Offices-Cancer Care
3400 Ministry Pkwy, Weston, WI 54476
Other Locations
Marshfield Medical Center-Stevens Point Campus-Cancer Center
4100 State Highway 66, Stevens Point, WI 54482

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

34 Clinical Trials

Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI)
Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI)
Enrollment Status: Recruiting
Publish Date: March 05, 2026
Intervention Type: Other
Cancer Moonshot Biobank Research Protocol
Cancer Moonshot Biobank Research Protocol
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Procedure, Other
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Exemestane, Letrozole, Systemic Chemotherapy
Study Phase: Phase 3
Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Other, Drug
Study Drug: Erlotinib Hydrochloride
Study Phase: Phase 3
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 3
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Other, Procedure
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Other, Procedure, Biological, Drug
Study Phase: Not Applicable
Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
Enrollment Status: Active_not_recruiting
Publish Date: March 23, 2026
Intervention Type: Other, Procedure
Study Phase: Phase 3
A Phase II Study of LOXO-292 in Patients With RET Fusion-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub-Study)
A Phase II Study of LOXO-292 in Patients With RET Fusion-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub-Study)
Enrollment Status: Active_not_recruiting
Publish Date: March 23, 2026
Intervention Type: Drug
Study Drug: Selpercatinib
Study Phase: Phase 2
View 9 Less Clinical Trials

118 Total Publications

Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005.
Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 13, 2026
Similar Doctors
Expertise in
35
conditions
Dr. Niaz Haque
Hematology | Oncology
Expertise in
35
conditions
Dr. Niaz Haque
Hematology | Oncology

Aspirus Regional Cancer Center

215 N 28th Ave, 
Wausau, WI 
 (29.7 miles away)
715-847-2866
Languages Spoken:
English
See accepted insurances

Niaz Haque is a Hematologist and an Oncologist practicing medicine in Wausau, Wisconsin. Dr. Haque is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Cervical Cancer, and Bone Marrow Aspiration.

Expertise in
58
conditions
Dr. Christopher Peterson
Oncology
Expertise in
58
conditions
Dr. Christopher Peterson
Oncology

Aspirus Regional Cancer Center

215 N 28th Ave, 
Wausau, WI 
 (29.7 miles away)
715-847-2866
Languages Spoken:
English
See accepted insurances

Christopher Peterson is an Oncologist practicing medicine in Wausau, Wisconsin. Dr. Peterson is highly rated in 58 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Multiple Myeloma, Colorectal Cancer, and Bone Marrow Aspiration.

Expertise in
28
conditions
Dr. Seth Fagbemi
Oncology
Expertise in
28
conditions
Dr. Seth Fagbemi
Oncology

Marshfield Medical Center-Marshfield Medical Offices Cancer Care

1000 N Oak Ave, 
Marshfield, WI 
 (32.4 miles away)
715-387-5416
Experience:
44+ years
Languages Spoken:
English
See accepted insurances

Seth Fagbemi is an Oncologist practicing medicine in Marshfield, Wisconsin. He has been practicing medicine for over 44 years. Dr. Fagbemi is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Inflammatory Breast Cancer, Familial Colorectal Cancer, WT1-Related Wilms Tumor Syndromes, Bone Marrow Transplant, and Prostatectomy.

Frequently Asked Questions about Dr. Adedayo Onitilo

How do I make an appointment with Dr. Adedayo Onitilo?

You can book an appointment with Dr. Adedayo Onitilo by calling their office at 715-393-1400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Adedayo Onitilo a top-rated expert for Neuroendocrine Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Adedayo Onitilo is classified as an Distinguished expert for Neuroendocrine Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Adedayo Onitilo specialize in?

While Dr. Adedayo Onitilo is a Oncology, they have specific expertise in Neuroendocrine Tumor, Breast Cancer, and Colorectal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Adedayo Onitilo participate in research or clinical trials?

Yes. Dr. Adedayo Onitilo has published 118 articles and abstracts on conditions like Neuroendocrine Tumor. You can view a list of Dr. Adedayo Onitilo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Adedayo Onitilo accept my insurance?

Dr. Adedayo Onitilo accepts most major insurance plans, including Anthem BCBS and Aspirus Arise Health Plan. We recommend calling the office directly at 715-393-1400 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Onitilo's expertise for a condition
ConditionClose
    View All 21 Distinguished Conditions
    View All 41 Advanced Conditions
    View All 124 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile